Abstract: A method for operating an exhaust system of an internal combustion engine, wherein nitrogen oxide (NOx) is reduced by use of a SCR catalytic converter and wherein the ageing state of the SCR catalytic converter is monitored, characterized in that during a temporally limited phase having a high proportion of nitrogen oxide (NOx) in the exhaust gas, a conversion of said SCR catalytic converter is acquired and evaluated and the ageing state of said SCR catalytic converter is suggested therefrom.

Abstract: A method for monitoring a nitrogen oxide storage catalytic converter (NSC) in the exhaust gas duct of an internal combustion engine which is operated at least temporarily in a lean fashion, wherein during a lean mode of the internal combustion engine nitrogen oxides from the exhaust gas are stored by the nitrogen oxide storage catalytic converter, wherein during a regeneration phase of the nitrogen oxide storage catalytic converter the internal combustion engine is operated in a rich fashion, and as a result the nitrogen oxides stored in the nitrogen oxide storage catalytic converter are removed, and wherein an exhaust gas component or exhaust gas characteristic variable which is characteristic of the profile of the regeneration is detected during the regeneration phase by means of an exhaust gas probe.

Abstract: The present invention provides methods and kits for improving the progression-free survival of a patient suffering from gastrointestinal cancer and for assessing the sensitivity or responsiveness of the patient to treatment comprising bevacizumab.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: A digital rights management system includes an authentication module and a decryption module. If desired, the modules can be implemented in separate integrated circuits. The authentication module retrieves authentication information for protected content and powers down after the authentication information is retrieved. The decryption module decrypts the protected content based on the authentication information while the authentication module is powered down.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: A method for cleaning the exhaust gas of an internal combustion engine, wherein nitrogen oxide in the exhaust gas is converted by means of hydrocarbons metered in a pulsed form into the exhaust gas duct, upstream of a nitrogen oxide catalytic converter.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: Disclosed herein are methods and compositions useful for identifying therapies likely to confer optimal clinical benefit for patients with cancer.

Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.

Abstract: The present invention relates to a novel crystalline modification of fipronil, to a process for the preparation of the same, to pesticidal and parasiticidal mixtures and compositions comprising said crystalline modification and to their use for combating pests and parasites.

Abstract: Method for compensating illumination deficiencies in microscopic “shape from focus (SFF)”, wherein firstly the reflectance of the scene is estimated by way of a projector-camera system and then microscopic “shape from focus (SFF)” is applied to a stack of reflectance maps rather than to the original image data.

Abstract: The present invention relates to a crystalline modification of fipronil, to a process for the preparation of the same, to pesticidal and parasiticidal mixtures and compositions comprising said crystalline modification and to their use for combating pests and parasites.

Abstract: A method for operating an exhaust system of an internal combustion engine, wherein nitrogen oxide (NOx) is reduced by use of a SCR catalytic converter and wherein the ageing state of the SCR catalytic converter is monitored, characterized in that during a temporally limited phase having a high proportion of nitrogen oxide (NOx) in the exhaust gas, a conversion of said SCR catalytic converter is acquired and evaluated and the ageing state of said SCR catalytic converter is suggested therefrom.

Abstract: The present invention relates to methods for improving the overall survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the vascular endothelial growth factor receptor 1 (VEGFR-1) gene. The present invention further provides methods for improving the progression-free survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the VEGFR-1 gene. The present invention also provides for methods for assessing the responsiveness of a patient to an angiogenesis inhibitor by determining the presence of one or more variant alleles of the VEGFR-1 gene.

Abstract: The invention concerns a procedure to determine the sulfur removal of a NOx storage catalytic converter in an exhaust gas aftertreatment system of an internal combustion engine, whereby conditions, in which a surplus of the reducing agent is generated in the internal combustion engine, are adjusted in the internal combustion engine for the sulfur removal, whereby a SOx removal amount is determined in a SOx removal calculation using a model from the reducing agent flow and from additional operating parameters of the internal combustion engine. In so doing, dynamic effects during the desulferization of the NOx storage catalytic converter can be better taken into account for the SOx removal calculation; and in so doing, the subsequent effect of the NOx storage catalytic converter on the reduction of the nitrogen oxides in the exhaust gas can be more accurately predicted, which makes the process management more streamlined and consequently more fuel efficient.